Exane Derivatives’s Raymond James Financial RJF Stock Holding History

Exane Derivatives’s Portfolio RJF Stock Details RJF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$101K	Sell	1,130 -1,517	-57%	-$149K	0.06%	262
2022 Q1	$291K	Buy	2,647 +1,406	+113%	+$149K	0.08%	252
2021 Q4	$125K	Sell	1,241 -219	-15%	-$21.6K	0.03%	417
2021 Q3	$135K	Buy	1,460 +728	+99%	+$65.2K	0.03%	486
2021 Q2	$65.1K	Buy	+732	New	+$63.7K	0.01%	606

Other funds holding RJF

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Exane Derivatives's RJF Position: Q2 2022 in Review

Exane Derivatives reduced its Raymond James Financial (RJF) stake by 57% in Q2 2022, selling an estimated $149K and leaving 1,130 shares worth $101K. The position accounts for 0.06% of the portfolio, ranked #262.

Exane Derivatives first reported a position in RJF in Q2 2021 and has held it in 5 quarters since. The position peaked at $291K in Q1 2022. 656 funds tracked by Wall St. Rank hold RJF as of Q2 2022.

Exane Derivatives held 1,130 shares of Raymond James Financial worth $101K as of Q2 2022.
Exane Derivatives sold 1,517 Raymond James Financial shares in Q2 2022, an estimated $149K.
Raymond James Financial made up 0.06% of Exane Derivatives's portfolio in Q2 2022, its #262 holding.
Exane Derivatives first reported a position in Raymond James Financial in Q2 2021 and has held it in 5 quarters since.
Exane Derivatives's Raymond James Financial position peaked at $291K in Q1 2022.
656 funds tracked by Wall St. Rank held Raymond James Financial as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.